Άρθρα με εντολές δημόσιας πρόσβασης - Wendy R. ParulekarΜάθετε περισσότερα
Δεν είναι διαθέσιμο πουθενά: 9
Intergroup randomized phase III study of androgen deprivation therapy (ADT) plus radiation therapy (RT) in locally advanced prostate cancer (CaP)(NCIC-CTG, SWOG, MRC-UK, INT …
PR Warde, MD Mason, MR Sydes, MK Gospodarowicz, GP Swanson, ...
Journal of Clinical Oncology 28 (18_suppl), CRA4504-CRA4504, 2010
Εντολές: US National Institutes of Health
Overall survival of men with metachronous metastatic hormone-sensitive prostate cancer treated with enzalutamide and androgen deprivation therapy
CJ Sweeney, AJ Martin, MR Stockler, S Begbie, KN Chi, S Chowdhury, ...
European Urology 80 (3), 275-279, 2021
Εντολές: National Health and Medical Research Council, Australia, Canadian Cancer Society
Development and validation of a nomogram to predict lymphedema after axillary surgery and radiation therapy in women with breast cancer from the NCIC CTG MA. 20 randomized trial
JP Gross, TJ Whelan, WR Parulekar, BE Chen, AW Rademaker, ...
International Journal of Radiation Oncology* Biology* Physics 105 (1), 165-173, 2019
Εντολές: US National Institutes of Health, Canadian Cancer Society
Predictive model for survival in patients having repeat radiation treatment for painful bone metastases
E Chow, K Ding, WR Parulekar, RKS Wong, YM van der Linden, D Roos, ...
Radiotherapy and Oncology 118 (3), 547-551, 2016
Εντολές: US National Institutes of Health, Canadian Cancer Society, Dutch Cancer Society
Anthracycline-induced cardiotoxicity in patients with early-stage breast cancer: the Canadian Cancer Trials Group (CCTG) MA. 21 experience
SF Dent, J Botros, M Rushton, O Aseyev, MN Levine, WR Parulekar, ...
Breast Cancer Research and Treatment 184, 733-741, 2020
Εντολές: US National Institutes of Health, Canadian Cancer Society, Canadian …
Demonstrating noninferiority of accelerated radiotherapy with panitumumab vs standard radiotherapy with cisplatin in locoregionally advanced squamous cell head and neck carcinoma
D Cheng, K Pak, LJ Wei
JAMA oncology 3 (10), 1430-1431, 2017
Εντολές: US National Institutes of Health
Cancer patients’ acceptability of incorporating an epidemiology questionnaire within a clinical trial
S Cuffe, H Hon, K Tobros, O Espin-Garcia, Y Brhane, L Harland, E Fadhel, ...
Clinical Trials 12 (3), 237-245, 2015
Εντολές: Canadian Cancer Society
Refining Risk Stratification of High-risk and Locoregional Prostate Cancer: A Pooled Analysis of Randomized Trials
P Ravi, W Xie, M Buyse, S Halabi, PW Kantoff, O Sartor, G Attard, ...
European Urology, 2024
Εντολές: UK Medical Research Council
Randomised Trial of No, Short-term, or Long-term Androgen Deprivation Therapy with Postoperative Radiotherapy After Radical Prostatectomy: Results from the Three-way Comparison …
CC Parker, NW Clarke, AD Cook, PM Petersen, CN Catton, WR Cross, ...
European Urology, 2024
Εντολές: Cancer Research UK, UK Medical Research Council, National Institute for …
Διαθέσιμο κάπου: 52
SPIRIT 2013 statement: defining standard protocol items for clinical trials
AW Chan, JM Tetzlaff, DG Altman, A Laupacis, PC Gøtzsche, ...
Annals of internal medicine 158 (3), 200-207, 2013
Εντολές: Canadian Institutes of Health Research
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
AW Chan, JM Tetzlaff, PC Gøtzsche, DG Altman, H Mann, JA Berlin, ...
Bmj 346, 2013
Εντολές: Canadian Institutes of Health Research
Regional nodal irradiation in early-stage breast cancer
TJ Whelan, IA Olivotto, WR Parulekar, I Ackerman, BH Chua, A Nabid, ...
New England Journal of Medicine 373 (4), 307-316, 2015
Εντολές: US National Institutes of Health, Canadian Cancer Society, Natural Sciences …
Enzalutamide with standard first-line therapy in metastatic prostate cancer
ID Davis, AJ Martin, MR Stockler, S Begbie, KN Chi, S Chowdhury, ...
New England Journal of Medicine 381 (2), 121-131, 2019
Εντολές: National Health and Medical Research Council, Australia, Canadian Cancer Society
Extending aromatase-inhibitor adjuvant therapy to 10 years
PE Goss, JN Ingle, KI Pritchard, NJ Robert, H Muss, J Gralow, K Gelmon, ...
New England Journal of Medicine 375 (3), 209-219, 2016
Εντολές: US National Institutes of Health, Canadian Cancer Society
Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial
P Warde, M Mason, K Ding, P Kirkbride, M Brundage, R Cowan, ...
The Lancet 378 (9809), 2104-2111, 2011
Εντολές: US National Institutes of Health, Cancer Research UK
Metastasis-free survival is a strong surrogate of overall survival in localized prostate cancer
W Xie, MM Regan, M Buyse, S Halabi, PW Kantoff, O Sartor, H Soule, ...
Journal of Clinical Oncology 35 (27), 3097-3104, 2017
Εντολές: US National Institutes of Health, UK Medical Research Council
Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer …
R Gray, R Bradley, J Braybrooke, Z Liu, R Peto, L Davies, D Dodwell, ...
The lancet 393 (10179), 1440-1452, 2019
Εντολές: US National Institutes of Health, Cancer Research UK, UK Medical Research …
Timing of radiotherapy after radical prostatectomy (RADICALS-RT): a randomised, controlled phase 3 trial
CC Parker, NW Clarke, AD Cook, HG Kynaston, PM Petersen, C Catton, ...
The Lancet 396 (10260), 1413-1421, 2020
Εντολές: US National Institutes of Health, Canadian Cancer Society, Cancer Research …
Final report of the intergroup randomized study of combined androgen-deprivation therapy plus radiotherapy versus androgen-deprivation therapy alone in locally advanced …
MD Mason, WR Parulekar, MR Sydes, M Brundage, P Kirkbride, ...
Journal of Clinical Oncology 33 (19), 2143-2150, 2015
Εντολές: US National Institutes of Health, Canadian Cancer Society, UK Medical …
SPIRIT 2013 Statement: defining standard protocol items for clinical trials
AW Chan, JM Tetzlaff, DG Altman, A Laupacis, PC Gøtzsche, ...
Revista Panamericana de Salud Pública 38, 506-514, 2015
Εντολές: Canadian Institutes of Health Research
Τα στοιχεία έκδοσης και χρηματοδότησης καθορίζονται αυτόματα από ένα πρόγραμμα υπολογιστή